Lentiviral vector-based therapy in head and neck cancer (Review)

Oncology Letters
Deepak UpretiSam K P Kung

Abstract

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common neoplasm worldwide. Despite advances in multimodality treatments involving surgery, radiation and chemotherapy, the five-year survival rate has remained at ~50% for the past 35 years. Therefore, the early detection of recurrent or persistent disease is extremely important. Replication-incompetent HIV-1-based lentiviral vectors have emerged as powerful and safe tools for gene delivery. Commonly, HNSCC is a locoregional disease that presents at or close to the body surface. Thus, HNSCC is amendable to intratumoral injections of gene therapy vectors aimed at correcting defects associated with tumor suppressor genes to induce the direct cytotoxicity of cancer cells or immune modulation to promote antitumor immunity. Current investigations analyzing HNSCC gene mutations and stem cell markers and the cancer immunoediting concept are creating exciting therapeutic opportunities for lentiviral and other gene transfer vectors. The present review reports specific examples of the current applications of lentiviral vectors in HNSCC.

References

Sep 5, 1990·Journal of the National Cancer Institute·S FranceschiC La Vecchia
Oct 1, 1988·Scandinavian Journal of Work, Environment & Health·O AxelsonG Wingren
Apr 1, 1994·European Journal of Immunology·J Péguet-NavarroD Schmitt
Jan 1, 1993·Journal of Cellular Biochemistry. Supplement·J R Grandis, D J Tweardy
May 19, 1997·The Journal of Experimental Medicine·S ValituttiA Lanzavecchia
Jun 13, 1998·Journal of the National Cancer Institute·J Rubin GrandisD J Tweardy
Jul 22, 1998·Journal of Immunotherapy·T E ReichertT L Whiteside
Aug 26, 1998·Archives of Otolaryngology--head & Neck Surgery·F M GonzálezA Durántez
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·S S CaseG M Crooks
Apr 14, 1999·CA: a Cancer Journal for Clinicians·D M ParkinJ Ferlay
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·R SchroersS Y Chen
Dec 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·B AlmandD I Gabrilovich
Dec 21, 2000·Current Oncology Reports·T L Whiteside
Mar 22, 2002·Nature Reviews. Immunology·A Cerwenka, L L Lanier
May 7, 2002·Nature Reviews. Cancer·Mikala Egeblad, Zena Werb
Jul 12, 2002·Current Gene Therapy·L J Chang, E E Gay
Sep 5, 2002·Nature Reviews. Cancer·Christopher Mark Overall, Carlos López-Otín
Sep 13, 2002·Immunology·Stephen Todryk
Oct 31, 2002·Nature Immunology·Gavin P DunnRobert D Schreiber
Dec 13, 2002·Vaccine·Michael CampoliSoldano Ferrone
Jan 2, 2003·Nature Reviews. Cancer·Patricia S Steeg
Dec 11, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sam K P KungRobert E Donahue
Feb 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fabrice AndréLaurence Zitvogel
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstDavid H Johnson
Mar 23, 2004·Annual Review of Immunology·Wayne M YokoyamaAnthony R French
May 29, 2004·Journal of Clinical Pathology·A NoelJ M Foidart
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Iris KussTheresa L Whiteside
Jul 13, 2004·Seminars in Cancer Biology·Fran Balkwill
Sep 7, 2004·The International Journal of Developmental Biology·Alicia R FolguerasCarlos López-Otín
Oct 1, 2004·Arthritis and Rheumatism·Ethan M Shevach
Nov 4, 2004·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Anthony SparanoM Rita I Young
Jan 12, 2005·The Journal of Pathology·Guillermina Lozano, Gerard P Zambetti

❮ Previous
Next ❯

Citations

Sep 20, 2016·Scientific Reports·Yunceng WengChengyao Li
Aug 7, 2014·Journal of Cancer Epidemiology·Zohaib KhanSteffen Müller
Aug 27, 2015·Journal of Dental Research·A C BirkelandM E Prince
Jul 30, 2014·Molecular Cancer·Chong-kui SunQian-ming Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.